Clinical Trial

Effect of Testofen on Erectile Function in an Adult Male Population

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a double blind, randomised, placebo-controlled clinical study with a 12-week participation and 3 groups (2 active groups and 1 placebo group) designed to monitor erectile function symptom severity and the effect Testofen may have on improving erectile function, sexual function, and quality of life.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-01-30; most recent amendment 2026-07-23.
Status change: Recruiting → Active, Not Recruiting 2026-07-20
Status change: Not Yet Recruiting → Recruiting 2022-05-18
Trial Details
NCT Number NCT05232279
Lead Sponsor RDC Clinical Pty Ltd
Collaborators: Pharmako Biotechnologies Pty Ltd, Gencor Pacific Limited, Hong Kong
Conditions Erectile Dysfunction
Enrollment 120 participants
Start Date 2022-04-19
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-27